Related Experiment Video
Updated: Apr 25, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
SIRT2 enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced nigrostriatal damage via apoptotic pathway
Lei Liu1, Anirudh Arun1, Lakia Ellis1
1Department of Neuroscience, Tufts University School of Medicine Boston, MA, USA.
Abstract:
Sirtuins are NAD-dependent protein deacetylases that were shown to have protective effects against different age-related diseases. SIRT2 is a strong deacetylase that is highly expressed in brain. It has been associated with neurodegenerative diseases. MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is a dopaminergic neurotoxin that displays clinical features of Parkinson's Disease (PD). MPTP leads to the degeneration of nigrostriatal dopaminergic pathway after its systemic administration. Chronic administration of MPTP induces lesion via apoptosis. We show here that SIRT2 deacetylates Foxo3a, increases RNA and protein levels of Bim, and as a result enhances apoptosis in the MPTP model of PD. We also show that neurodegeneration induced by chronic MPTP regimen is prevented by genetic deletion of SIRT2 in mouse. Deletion of SIRT2 leads to the reduction of apoptosis due to an increase in acetylation of Foxo3a and a decrease in Bim levels. We demonstrate that SIRT2 deacetylates Foxo3a, activates Bim, and induces apoptosis only in MPP(+)-treated cells. Therefore, designing SIRT2 inhibitors might be helpful in developing effective treatments for PD.
Insights
Sirtuin 2 (SIRT2) promotes apoptosis in Parkinson's Disease models by deacetylating Foxo3a, increasing Bim levels. Inhibiting SIRT2 may offer a novel therapeutic strategy for Parkinson's Disease.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Sirtuins, particularly SIRT2, are implicated in neurodegenerative diseases.
- MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is a neurotoxin modeling Parkinson's Disease (PD).
- MPTP induces dopaminergic neuron apoptosis.
Purpose of the Study:
- To investigate the role of SIRT2 in MPTP-induced neurodegeneration.
- To elucidate the molecular mechanism by which SIRT2 affects apoptosis in PD models.
Main Methods:
- Utilized the MPTP mouse model of Parkinson's Disease.
- Investigated the effects of genetic deletion of SIRT2 on neurodegeneration and apoptosis.
- Examined the interaction between SIRT2, Foxo3a, and Bim in cellular and animal models.
Main Results:
- SIRT2 deacetylates Foxo3a, upregulating Bim and enhancing apoptosis in MPTP-treated cells.
- Genetic deletion of SIRT2 prevented MPTP-induced neurodegeneration by increasing Foxo3a acetylation and decreasing Bim levels.
- SIRT2-mediated Foxo3a deacetylation and Bim activation were observed in MPP(+)-treated cells.
Conclusions:
- SIRT2 plays a critical role in mediating apoptosis in Parkinson's Disease models.
- Targeting SIRT2 with inhibitors could be a potential therapeutic approach for Parkinson's Disease.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
The Intrinsic Apoptotic Pathway
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
The Extrinsic Apoptotic Pathway
Parkinson Disease ll: Pathophysiology
Abnormal Proliferation

